TLRY

Tilray Inc

Dow Jones

Dow Jones Industrial Average Slides 18 Points as Chinese Economy Shows Signs of Weakness

The Dow Jones Industrial Average fell slightly in premarket trading as investors weighed the impact of the ongoing trade war escalation between the United States and China.

This morning, China's Premier Li Keqiang said during World Economic Forum conference in China that his nation is facing "greater difficulties in keeping stable performance of the Chinese economy."

Trading Strategies

Why 398% Profits Are Just the Start for This "World-Beating" Pot Stock

There are many recipes for a soaring stock price.

Here's one I like a lot…

1. A company that taps into previously prohibited yet well-established markets

2. Excellent leadership skills

3. A killer execution strategy

And that's precisely what we've been seeing with a firm I mentioned most recently back in mid-July.

At that time, I told you how this company became the world's first seed-to-sale cannabis outfit ever to make its initial public offering on a major U.S. stock exchange.

During its IPO, the company raised about $164 million, which it's plowing directly into building out its cannabis cultivation and processing capacity, among other projects.

And it just secured an important new "gig" that sent its shares soaring as high as 32% yesterday… Full Story

And it just secured an important new "gig" that sent its shares soaring as high as 32% yesterday...

Trading Strategies

Cash Runs to Quality in This Growing $1.5 Billion Cannabis Niche

Every investor should understand how the market for cannabis is developing – now and over the coming weeks, months, and years.

Choosing the companies best positioned to profit in the emerging market helps you gain an edge over those who simply "throw darts at a list of stocks" and pick cannabis companies without regard to industry realities.

But as legalization becomes more widespread throughout the United States and across the whole of Canada, investors still face questions about what the realities of a mature cannabis market might be.

For some answers, we can look at Colorado – the first U.S. state to make recreational cannabis easily available.

That made some realities evident.

We know, for example, that in places where vaporizing (aka "vaping") cannabis concentrate is legal, that form quickly takes over a significant part of the market.

Vaporizable concentrates are a value-added product, but they're also fairly commoditized, meaning customers shop by product attributes, such as how rigorously it's been tested, say, or the ratio of THC to CBD, as opposed to shopping by brand.

The traditional marijuana bud, or "flower," market, which in Canada is worth about $1.5 billion today, is still fragmented. Customers there are still experimenting with different strains, different growers and brands, and different cannabinoids and THC to CBD ratios. In other words, there are a lot of questions.

One big question facing the market – both in Colorado and worldwide – is whether consumers are willing to pay up for "super-premium" cannabis. That is, cannabis that is more expensive to produce… but that generates a better smoking experience.

There are many producers claiming to grow such cannabis – that's why it's such a big question. After all, no one is going to advertise that they make the lowest-end cannabis on the market any more than Busch admits that its beer is lower-end than a craft brewer's.

So how can an investor tell when a company is really producing super-premium cannabis… or merely claiming to grow it?

That's a very important question because, naturally, the investment case for the genuine super-premium product tends to be much stronger than it might be for the pretenders.

One company last week gave us the answer, loud and clear...

Marijuana Industry

Ignore These Cannabis Industry Misconceptions and Book Triple-Digit Gains

The legal cannabis industry will grow 145% from $10 billion in sales in 2017 to $24.5 billion by 2021, but there are still misconceptions about the billion-dollar market.

Workers are lazy. Building a cannabis business is easy. Marijuana dispensaries attract crime. You'll lose all your money investing in marijuana stocks.

But these misconceptions can lead to missed profit opportunities through pot stocks...

IPOs

The U.S. Cannabis IPO Wave Will Be a Massive Payday

Canada's fully legal "adult use" marijuana market throws the wild success of Canadian cannabis stocks into sharp relief…

In just the past year, Canopy Growth is up over 416%.

Cronos Group is up over 301% in that same time.

And Tilray, which only went public in mid-July, is up 577%.

These gains raise an important question: How can you make money on U.S.-based cannabis companies during this historic growth cycle?

After all, at about $8.5 billion, the United States cannabis industry is already larger than the Canadian market is projected to grow by 2022. And that growth isn't going to slow down anytime soon – Arcview Market Research and BDS Analytics project that cannabis spending in the United States will reach $23.4 billion by 2022, a 275% increase in just five years.

That's an extremely conservative estimate, by the way, in that it assumes few, if any, additional states will legalize cannabis for recreational use. But because other states are coming on board and will likely continue to do so, other estimates have the market growing to $50 billion by 2022 – a 42.5% annual growth rate.

Yet there are no fewer than seven Canadian cannabis companies with a market value in excess of $1 billion, compared with only one U.S.-based outfit.

I'm looking for that to change – in a big way.

This will give you an idea of the size of the potential opportunity on our hands...